返回 
加入收藏
静脉药物配置中公共卫生风险的识别与防控策略综述
x
请在关注微信后，向客服人员索取文件
| 篇名： | 静脉药物配置中公共卫生风险的识别与防控策略综述 |
| TITLE： | Review on identification and prevention-control strategies for public health risks in pharmacy intravenous admix-ture services |
| 摘要： | 静脉药物配置作为临床用药供给链的核心环节，直接关联药品安全性与患者用药安全。本文梳理了静脉药物配置中处方审核、药品配制、药品管理、成品流转与追溯等实操环节的可能公共卫生风险防控难点和措施，并基于“预防-管控-应急”全链条管理理念，提出系统性防控策略，如构建“公共卫生导向”的静脉用药调配中心管理制度体系、强化全流程风险干预措施、健全风险监测与应急响应机制、推动技术赋能、完善药师培训与人员资质管控机制等，以期构建起从“被动应对”到“主动防控”的全链条公共卫生安全体系，保障患者用药安全。 |
| ABSTRACT： | Pharmacy intravenous admixture serves as a core link in the clinical medication supply chain. Its operational quality is directly related to drug safety and patient medication safety. This paper examines the challenges and measures for public health risk prevention and control in practical operational aspects of intravenous drug preparation， including prescription verification， drug compounding， drug management， and finished product distribution and traceability. Grounded in the “prevention-control-emergency response” full-chain management framework， it proposes systematic prevention and control strategies， including establishing a “public health-oriented” pharmacy intravenous admixture service management system， strengthening risk intervention measures throughout the entire process， improving risk monitoring and emergency response mechanisms， promoting technological empowerment， and refining pharmacist training and personnel qualification control mechanisms. These efforts aim to establish a comprehensive public health safety system that shifts from a “passive response” to an “active prevention and control” approach， thereby ensuring patient medication safety. |
| 期刊： | 2026年第37卷第02期 |
| 作者： | 蒋琳；张天竹 |
| AUTHORS： | JIANG Lin，ZHANG Tianzhu |
| 关键字： | 静脉用药配置；公共卫生风险；用药安全；风险识别 |
| KEYWORDS： | pharmacy intravenous admixture services； public health risks； medication safety； risk identification |
| 阅读数： | 10 次 |
| 本月下载数： | 0 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
